Clinical Trials Directory

Trials / Completed

CompletedNCT00639444

Risk of Celiac Disease and Age at Gluten Introduction

Infant Nutrition and Development of Celiac Disease in Genetically At-risk Babies: a Dietary Intervention Study at Weaning

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
703 (actual)
Sponsor
Università Politecnica delle Marche · Academic / Other
Sex
All
Age
1 Day – 6 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether age at introduction of gluten-containing cereals (e.g. wheat) plays a role in influencing the risk of celiac disease (CD) development in infants with a first-degree relative affected by CD.

Detailed description

We undertook a prospective study to establish the incidence of CD autoimmunity related to the timing of gluten exposure in at-risk infants. Infants at family risk for CD (at least one first-degree relative affected) are enrolled in this prospective, multicentre, intervention study conducted in Italy. Infants are randomly assigned to introduce gluten at either 4-6 or 12 months (groups A and B, respectively) and then enter a follow-up period of 5 years. Duration of breastfeeding and types of formulas, adherence to the dietary plan, amount of gluten administered, and clinical data are collected by phone or direct interview at 4, 7, 9, and 12 months of age. HLA (Human Leucocyte Antigene) status and CD serology (anti-transglutaminase and other autoantibodies) are tested at 15, 24, 36 and 60 months of age.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTgluten-free, normocaloric diet from 6 to 12 monthsGluten-containing cereals (wheat, rye and barley) will be replaced by gluten-free starchy food (rice, corn, tapioca-based, etc) in a normocaloric diet

Timeline

Start date
2004-09-01
Primary completion
2007-12-01
Completion
2013-11-01
First posted
2008-03-20
Last updated
2013-12-10

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00639444. Inclusion in this directory is not an endorsement.